Evidence map›Paper›PMID 32055737›Full record

ReviewHeliyon2020

Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering.

Joham Surfraz Ali, Noor Ul Ain, Sania Naz, Muhammad Zia

Abstract readReview
In one paragraph

Review in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joham Surfraz AliDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan.
Noor Ul AinDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan.
Sania NazDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan.
Muhammad ZiaDepartment of Biotechnology, Quaid-i-Azam University Islamabad 45320 Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant cells reprogram metabolic pathways to meet the demands of growth and proliferation. These altered manners of metabolism are now identified as hallmarks of cancer. Studies have revealed tumor cells alter specific pathways such as glycolysis, fatty acid synthesis and amino acid synthesis to support their proliferation. In this review, we provide a theoretical framework to understand metabolic reprogramming and the mechanisms accompanying distorted metabolism to tumor progression. How these alterations will be assisting in cancer diagnostics and advances in standard techniques in marker identification and imagining are also discussed.

Indexed as

BiochemistryCancerCancer researchCell differentiationDOPAImagingMedical imagingMetabolic pathwayMetabolomicsMRINuclear medicinePETSPECT

Identifiers

PMID32055737
PMCPMC7005466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.